Filing Details
- Accession Number:
- 0001209191-14-041398
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-06-13 18:23:36
- Reporting Period:
- 2014-06-13
- Filing Date:
- 2014-06-13
- Accepted Time:
- 2014-06-13 18:23:36
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1123979 | Senomyx Inc | SNMX | Services-Commercial Physical & Biological Research (8731) | 330843840 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1473300 | E Antony Rogers | 4767 Nexus Centre Drive San Diego CA 92121 | Sr. V.p. & Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-06-13 | 2,997 | $6.02 | 42,791 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-06-13 | 2,997 | $8.41 | 39,794 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock option (right to buy) | Disposition | 2014-06-13 | 2,997 | $0.00 | 2,997 | $6.02 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2014-06-24 | No | 4 | M | Direct |
Footnotes
- The options exercised were scheduled to expire on June 24, 2014.
- Includes 9,355 shares of Common Stock that were acquired by the Reporting Person on 2/28/14, pursuant to the Issuer's Employee Stock Purchase Plan.
- Reported transaction occurred pursuant to Rule 10B5-1 Plan.
- In addition to the 39,794 shares of Common Stock beneficially owned, the Reporting Person also holds outstanding options to purchase 800,520 shares of Common Stock.
- The shares subject to the option are fully vested.